Dural and Leptomeningeal Diseases: Anatomy, Causes, and Neuroimaging Findings.
Kurokawa R, Kurokawa M, Isshiki S, Harada T, Nakaya M, Baba A, Naganawa S, Kim J, Bapuraj J, Srinivasan A, Abe O, Moritani T.
Radiographics. 2023 Aug;43(9):e230039. doi: 10.1148/rg.230039.
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J.
Cell. 2017 Mar 9;168(6):1101-1113.e13. doi: 10.1016/j.cell.2017.02.025.
Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis.
Schulz M, Salamero-Boix A, Niesel K, Alekseeva T, Sevenich L.
Front Immunol. 2019 Jul 24;10:1713. doi: 10.3389/fimmu.2019.01713. eCollection 2019.
Meningeal carcinomatosis.
HAWKINS D, BROWN D.
Can Med Assoc J. 1963 Feb 2;88(5):225-8.
Spatial transcriptomics analysis identifies a tumor-promoting function of the meningeal stroma in melanoma leptomeningeal disease.
Alhaddad H, Ospina OE, Khaled ML, Ren Y, Vallebuona E, Boozo MB, Forsyth PA, Pina Y, Macaulay R, Law V, Tsai KY, Cress WD, Fridley B, Smalley I.
Cell Rep Med. 2024 Jun 18;5(6):101606. doi: 10.1016/j.xcrm.2024.101606. Epub 2024 Jun 11.
An unexpected corridor to brain metastasis.
Monteran L, Erez N.
Science. 2024 Jun 21;384(6702):1302-1303. doi: 10.1126/science.adq4019. Epub 2024 Jun 20.
Neoplastic meningitis-related encephalopathy.
Chamberlain MC, Tsao-Wei D, Groshen S.
J Neurooncol. 2005 Apr;72(2):185-9. doi: 10.1007/s11060-004-2062-y.
Management of neoplastic meningitis.
Roth P, Weller M.
Chin Clin Oncol. 2015 Jun;4(2):26. doi: 10.3978/j.issn.2304-3865.2015.05.02.
Leptomeningeal carcinomatosis.
Grossman SA, Krabak MJ.
Cancer Treat Rev. 1999 Apr;25(2):103-19. doi: 10.1053/ctrv.1999.0119.
Neoplastic meningitis.
Kim L, Glantz MJ.
Curr Treat Options Oncol. 2001 Dec;2(6):517-27. doi: 10.1007/s11864-001-0073-x.
